Salk Institute for Biological Studies-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Salk Institute for Biological Studies - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013314
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise molecular biology and genetics, neurosciences, and plant biology. Its research provides development of new therapies and treatments for diseases such as cancer, AIDS, Alzheimer’s disease, cardiovascular disorders, anomalies of brain, birth defects, diabetes and metabolism, gene therapy, plant biology, vision, and williams syndrome, among others. Salk offers education outreach programs that delivers research impact on human health. The institute has neuroscience, molecular and cellular biology laboratories. Salk is headquartered in La Jolla, California, the US.

Salk Institute for Biological Studies – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ipsen Extends Research Agreement with Salk Institute for Biological Studies 10
Ipsen Extends Research Agreement With Salk Institute for Biological Studies 11
Licensing Agreements 12
Metacrine Enters into Licensing Agreement with Salk Institute for Biological Studies 12
StemCell Technologies Enters into Licensing Agreement with Salk Institute for BrainPhys 13
Mitobridge Enters into Licensing Agreement with Salk Institute for Biological Studies 14
Salk Institute for Biological Studies – Key Competitors 15
Salk Institute for Biological Studies – Key Employees 16
Salk Institute for Biological Studies – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Sep 19, 2017: CPRIT awards $34M to UTSW for cancer research recruitment 18
May 30, 2017: Brain’s immune cells linked to Alzheimer’s, Parkinson’s, schizophrenia 20
Feb 14, 2017: Salk scientist awarded inaugural Sjoberg Prize for cancer breakthrough 22
Nov 21, 2016: Salk Institute awarded $25 million grant from Helmsley Charitable Trust 23
Aug 25, 2016: Elevating brain protein allays symptoms of Alzheimer’s and improves memory 24
Jun 27, 2016: Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells 25
Mar 28, 2016: TSRI, Salk Scientists Discover ‘Outlier’ Enzymes that Could Offer New Targets to Treat Diabetes, Inflammation 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Key Facts 2
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Salk Institute for Biological Studies, Deals By Therapy Area, 2011 to YTD 2017 8
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ipsen Extends Research Agreement with Salk Institute for Biological Studies 10
Ipsen Extends Research Agreement With Salk Institute for Biological Studies 11
Metacrine Enters into Licensing Agreement with Salk Institute for Biological Studies 12
StemCell Technologies Enters into Licensing Agreement with Salk Institute for BrainPhys 13
Mitobridge Enters into Licensing Agreement with Salk Institute for Biological Studies 14
Salk Institute for Biological Studies, Key Competitors 15
Salk Institute for Biological Studies, Key Employees 16

★海外企業調査レポート[Salk Institute for Biological Studies-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bristow Group Inc:企業の戦略・SWOT・財務情報
    Bristow Group Inc - Strategy, SWOT and Corporate Finance Report Summary Bristow Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Grupo Televisa S.A.B.:企業の戦略・SWOT・財務情報
    Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Prosetta Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prosetta Biosciences Inc (Prosetta Biosciences), formerly Prosetta Antiviral Inc is a developer of novel small-molecule antiviral drugs based on research on the cell-free protein synthesizing systems. The company uses cell-free protein synthesizing systems to identify new protein-protein int …
  • BeyondSpring Inc (BYSI):製薬・医療:M&Aディール及び事業提携情報
    Summary BeyondSpring Inc (BeyondSpring) is a clinical stage biopharmaceutical company focused on the development of immune-oncology cancer therapies. The company offers lead compound, Plinabulin, is derived from a natural compound which holds a number of biochemical activities and provides multiple …
  • Trinity Industries, Inc (TRN):電力:M&Aディール及び事業提携情報
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • The Empire District Electric Company-エネルギー分野:企業M&A・提携分析
    Summary The Empire District Electric Company (EDE), a subsidiary of Liberty Utilities Co., is a regulated utility that provides electricity, natural gas, and water services. The company generates, procures, transmits, distributes, and sells electricity. It generates electricity from natural gas, coa …
  • RPM International Inc:企業の戦略・SWOT・財務情報
    RPM International Inc - Strategy, SWOT and Corporate Finance Report Summary RPM International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Silver Fern Farms Limited:企業の戦略的SWOT分析
    Silver Fern Farms Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Takasago International Corporation (4914):企業の財務・戦略的SWOT分析
    Takasago International Corporation (4914) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Hemanext:製薬・医療:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • Direct Flow Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Direct Flow Medical Inc (Direct Flow) is a medical device company that develops novel transcatheter heart valve technologies. The company provides transcatheter aortic valve implantation device without contrast. It also provides direct flow medical system, a technology for controlled and rel …
  • Duke Energy Corporation (DUK):電力:M&Aディール及び事業提携情報
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • Guizhou Space Appliance Co., Ltd.
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • S&C Electric Co:企業の戦略的SWOT分析
    S&C Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Hidd Power Company:企業の戦略的SWOT分析
    Hidd Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Deutsche Ruckversicherung AG:企業の戦略・SWOT・財務情報
    Deutsche Ruckversicherung AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Ruckversicherung AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Brown-Forman Corporation:戦略・SWOT・企業財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Esco Technologies Inc (ESE):企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SMART Global Holdings, Inc. (SGH):企業の財務・戦略的SWOT分析
    SMART Global Holdings, Inc. (SGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆